Safe Orthopaedics (ALSAF) Stock Statistics & Valuation Metrics
Total Valuation
Safe Orthopaedics has a market cap or net worth of EUR 115.98K. The enterprise value is EUR 10.58M.
- Market Cap
- EUR 115.98K
- Enterprise Value
- EUR 10.58M
Share Statistics
Safe Orthopaedics has 181,223 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 181,223
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Safe Orthopaedics’s return on equity (ROE) is 0.38 and return on invested capital (ROIC) is 0.00%.
- Return on Equity (ROE)
- 0.38
- Return on Assets (ROA)
- -0.35
- Return on Invested Capital (ROIC)
- 0.00%
- Return on Capital Employed (ROCE)
- 0.40
- Revenue Per Employee
- 70.13K
- Profits Per Employee
- -53.25K
- Employee Count
- 77
- Asset Turnover
- 0.46
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Safe Orthopaedics is -0.01. Safe Orthopaedics’s PEG ratio is -0.00.
- PE Ratio
- -0.01
- PS Ratio
- 0.02
- PB Ratio
- -0.01
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Safe Orthopaedics had revenue of 5.40M and earned -4.10M in profits. Earnings per share was -22.62.
- Revenue
- 5.40M
- Gross Profit
- 0
- Operating Income
- -3.50M
- Pretax Income
- 0
- Net Income
- -4.10M
- EBITDA
- -3.00M
- Earnings Per Share (EPS)
- -22.62
Cash Flow
In the last 12 months, operating cash flow was -2.06B and capital expenditures -88.00M, giving a free cash flow of -2.14B billion.
- Operating Cash Flow
- -2.06B
- Free Cash Flow
- -2.14B
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Safe Orthopaedics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -3539.36%
Stock Price Statistics
- Beta
- 0.50
- 52-Week Price Change
- -73.33%
- 50-Day Moving Average
- 0.64
- 200-Day Moving Average
- 0.72
- Relative Strength Index (RSI)
- 50.97
- Average Volume (3m)
- ―
Important Dates
Safe Orthopaedics upcoming earnings date is ―, After Close (Not Confirmed).
- Last Earnings Date
- Oct 10, 2023
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Safe Orthopaedics as a current ratio of 0.41, with Debt / Equity ratio of -126.44%
- Current Ratio
- 0.41
- Quick Ratio
- 0.26
- Debt to Market Cap
- 40.22
- Net Debt to EBITDA
- -4.37
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Safe Orthopaedics has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Safe Orthopaedics EV to EBITDA ratio is -1.72, with an EV/FCF ratio of 0.00.
- EV to Sales
- 2.45
- EV to EBITDA
- -1.72
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Safe Orthopaedics has EUR 317.00K in cash and marketable securities with EUR 11.79M in debt, giving a net cash position of -EUR 11.47M billion.
- Cash & Marketable Securities
- EUR 317.00K
- Total Debt
- EUR 11.79M
- Net Cash
- -EUR 11.47M
- Net Cash Per Share
- -EUR 63.30
- Tangible Book Value Per Share
- ―
Margins
Gross margin is -51.07%, with operating margin of -164.78%, and net profit margin of -75.93%.
- Gross Margin
- -51.07%
- Operating Margin
- -164.78%
- Pretax Margin
- -93.59%
- Net Profit Margin
- -75.93%
- EBITDA Margin
- -142.52%
- EBIT Margin
- -164.78%
Analyst Forecast
The average price target for Safe Orthopaedics is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- 7.12%
- EPS Growth Forecast
- 100.00%